To discuss how to build a more resilient drug supply chain. Experts, including drug manufacturers and policymakers, will describe the challenges we face in building a resilient drug supply chain, potential approaches to build a more robust, responsive, and resilient supply chain, and how we can assess our progress towards supply chain resilience.